Skip to main content
Menu

Opera Phenix OptIQ High-Content Screening System

The Opera Phenix OptIQ™ high-content imaging system delivers advanced confocal technology for complex, high-throughput applications. Built on two decades of innovation, this system excels at phenotypic screening and sophisticated imaging assays across diverse biological models including 3D organoids and organ-on-chip samples. Equipped with Harmony™ and Phenologic.AI™ image and analysis software, the Opera Phenix OptIQ offers an intuitive user interface for image acquisition, analysis, and evaluation.

What's new:

  • >95% QE camera(s)
  • Advanced laser-based autofocus
  • Hypoxia applications
  • 10x high NA lens
  • Phenologic.AI classification tools
  • Find Organoids building block
For research use only. Not for use in diagnostic procedures.
Part #: HH25000000
Imaging Modality:
Brightfield, Confocal, Digital phase contrast, Fluorescence

Loading...

Imaging just got smarter with the Opera Phenix OptIQ System

Discover more

High content imaging provides a greater depth of information than other approaches, allowing you to explore cellular processes in detail.

Quantify in detail

Analyze phenotypic changes at scale, from single cells to entire populations. High-content imaging empowers detailed quantification.

Enhance 3D imaging

Water immersion objectives elevate 3D image quality, revealing intricate details within complex biological structures.

Boost throughput

Add more cameras to increase speed and efficiency. High-content imaging accelerates your research pipeline.

Imaging just got smarter with the Opera Phenix OptIQ High-Content Screening System
Image acquisition and analysis simplified

Image acquisition and analysis simplified with Harmony software

Intuitive workflow

Harmony software offers an intuitive user interface that guides you from image acquisition to analysis and evaluation.

Templates for quick set-up

Templates allow you to set up acquisition channels and parameters efficiently.

Ready-made solutions

Choose from pre-built solutions for common image analysis tasks, simplifying your workflow.

Customizable building blocks

Create, configure, and customize your own high-content analysis applications using image analysis building blocks.

Advanced features

Harmony includes advanced analysis capabilities, such as texture and STAR morphology analysis, providing detailed descriptions of cellular morphology and robust differentiation of phenotypes.

Data management

The software automatically stores analysis results and metadata, including assay layout, instrument settings, and user-defined keywords and annotations.

AI-based image analysis

Using pre-trained deep-learning image-analysis models, Phenologic.AI allows for segmentation and classification of cells in brightfield and fluorescent images for easier analysis of live and fixed cell assays.

Overview

Opera Phenix OptIQ high-content screening system for your most demanding high-content applications.

  • Enhanced speed using a dual - or four-camera configuration with simultaneous imaging.
  • Synchrony Optics™ combines a microlens-enhanced Nipkow spinning disk with a pinhole distance optimized for thick and 3D samples.
  • Dual-view excitation of neighboring spectral channels minimizes crosstalk.
  • Custom-designed high-NA water immersion objectives capture more photons and provide high-image resolution even in thick samples.
  • Fast imaging frame rate of up to 100 fps and optional pipettor module captures fast cellular responses.

Specifications

Automation Compatible
Yes
Brand
Opera Phenix OptIQ
Imaging Modality
Brightfield
Confocal
Digital phase contrast
Fluorescence
Unit Size
1 unit

Citations

Resources

Are you looking for resources, click on the resource type to explore further.

1-6 of 20 Resources
Whitepaper Icon
Whitepaper
A brand-new modality on the horizon: how targeted protein degradation can address the unmet need in drug discovery and development

Targeted protein degradation (TPD) is an emerging drug discovery modality that offers the potential to probe biological pathways...

Whitepaper Icon
Whitepaper
An emerging therapeutic modality - RNA carves its path out of the paradigm

RNA-based therapeutics have garnered significant attention in recent years, fueled by the success of the mRNA COVID-19 vaccines...

Whitepaper Icon
Whitepaper
Artificial intelligence, machine learning and deep learning: applications in cellular imaging for improved drug discovery productivity

There has been a lot of buzz around artificial intelligence, machine learning and deep learning. Is the reality living up to the...

Whitepaper Icon
Whitepaper
Assessing juvenile batten disease on Brain Development in In Vitro 3D organoid models

Neuronal ceroid lipofuscinosis (NCL) is a complex, rare, and fatal disease belonging to a larger group of lysosomal storage...

Whitepaper Icon
Whitepaper
Cell painting - a cellular imaging and machine learning approach to drug discovery

Phenotypic Drug Discovery Re-Imagined

Cell Painting is a phenotypic screening method and a powerful application of high-content...

Whitepaper Icon
Whitepaper
COVID-19 therapeutics: demand, challenges, and the future

In a lively panel discussion, Dr. Kevin Coombs, Dr. Randal Ketchem, Dr. Mansoor Amiji, and Dr. Seyoum Ayehunie provided insights...

Loading...

Scroll Icon

Revvity AI Assistant Beta